Jade Biosciences JBIO

NASDAQ JBIO

$19.94 +0.09 (+0.48%)

As of: Sep 4, 2026 · 3:19 PM EDT

Jade Biosciences (JBIO) Interest Coverage Ratio (QoQ) (2021 - 2024)

Analysis

Jade Biosciences (JBIO) Interest Coverage Ratio (QoQ) (2021 - 2024) Analysis & Trends

Peer Set

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.43 Bn	130.58 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn
3	Argenx Se	63.34 Bn	58.15 Bn	1.37 Bn
4	Moderna	57.98 Bn	52.85 Bn	52.00 Mn
5	Revolution Medicines	43.98 Bn	43.98 Bn	-
6	BeOne Medicines	39.92 Bn	34.82 Bn	1.53 Bn
7	Alnylam Pharmaceuticals	35.42 Bn	32.11 Bn	992.69 Mn
8	Royalty Pharma	28.42 Bn	27.58 Bn	-
9	Insmed	27.36 Bn	26.20 Bn	358.27 Mn
10	Jade Biosciences	1.22 Bn	1.22 Bn	-

Historic Data

Historic Data

Download Data

Date	Value
Jun 30, 2024	46.86%
Jun 30, 2023	-15.29%
Jun 30, 2021	30.77%

Jade Biosciences

NASDAQ: JBIO

$19.94 ▲ +0.09 (+0.48%)

Sep 4, 2026 · 3:19 PM EDT